San Mateo, CA – According to filings with the U.S. Securities and Exchange Commission, Arda Therapeutics is raising $8,499,996.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Freund played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Arda Therapeutics
Arda is a seed stage platform therapeutics company developing immunotherapies to remove pathological cells in chronic diseases and aging.

To learn more about Arda Therapeutics, visit https://www.ardatherapeutics.com/

Contact:
Adam Freund, Chief Executive Officer
650-804-8953
https://www.linkedin.com/in/adam-freund-0657654/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved